510(k) device
Oncobionic System with 6 Probe Output
Oncobionics, Inc. · Low Energy Direct Current Thermal Ablation System (OAB, Class II) · First FDA decision Nov 21, 2006, newest May 8, 2008Tumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
1
Naming "Oncobionic"
MAUDE reports
0
Brand "Oncobionic", since 2015
PubMed studies
0
Mentioning "Oncobionic"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K080202 · Decided May 8, 2008 · 101 days after receipt
Device type: Low Energy Direct Current Thermal Ablation System (OAB) · General & Plastic Surgery
- ONCOBIONIC SYSTEM510(k)
K060054 · Decided Nov 21, 2006 · 319 days after receipt
Device type: Low Energy Direct Current Thermal Ablation System (OAB) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Oncobionic", any status and sponsor, newest update first.
Hospital Sirio-LibanesAcademic, hospital or other
NCT01641276 · 60 participants · Start Apr 2012 · Primary completion Jun 2015
Device: Low intensity amplitude-moduled electromagnetic fields · For: Hepatitis; Hepatocellular Carcinomas
Sites: São Paulo, Brazil
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Oncobionic", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OAB
114 reports: 47 malfunction, 59 injury, 8 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Angiodynamics Worldwide Headquarters
Z-0918-2012 · Started Jan 20, 2012 · Posted by FDA Jan 27, 2012
Reason given: Angiodynamics was marketing the NanoKnife System with the ablation zone estimator feature in the US without FDA clearance.
Cause as FDA categorized it: Labeling False and Misleading · Device type: Low Energy Direct Current Thermal Ablation System (OAB)
Published research
The most relevant PubMed records for "Oncobionic"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OAB.
- NanoKnife Generator (H78720300351US0)Angiodynamics · 510(k) 2026
- Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02)Hangzhou Ruidi Biotechnology , Ltd. · 510(k) 2026
- Aliya® EX SystemGalvanize Therapeutics, Inc. · 510(k) 2026
- Electroporation System (N3000)Surgnova Healthcare Technologies (Zhejiang) Co., Ltd. · 510(k) 2024
- INUMI Flex NeedleGalvanize Therapeutics, Inc. · 510(k) 2024
- Canady Helios Cold Plasma XL-1000CP Ablation System (XL-1000CPSYS)Us Medical Innovations, LLC · 510(k) 2024
- Irreversible Electroporation Ablation GeneratorZhejiang Curaway Medical Technology Co., Ltd. · 510(k) 2023
- Aliya(TM) System, Aliya(TM) Generator, Aliya(TM) Needle, Aliya(TM) ElectrodeGalvanize Therapeutics, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.